NDC 0404-9825

Brevibloc

Brevibloc

Brevibloc is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc. The primary component is Esmolol Hydrochloride.

Product ID0404-9825_d0ce9156-a586-4c84-8b7f-d327d71183e2
NDC0404-9825
Product TypeHuman Prescription Drug
Proprietary NameBrevibloc
Generic NameBrevibloc
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-01-09
Marketing CategoryNDA /
Application NumberNDA019386
Labeler NameHenry Schein, Inc
Substance NameESMOLOL HYDROCHLORIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0404-9825-10

1 VIAL, SINGLE-DOSE in 1 BAG (0404-9825-10) > 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-01-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Brevibloc" or generic name "Brevibloc"

NDCBrand NameGeneric Name
0404-9825BreviblocBrevibloc
10019-055BreviblocEsmolol Hydrochloride
10019-075BreviblocEsmolol Hydrochloride
10019-115BreviblocEsmolol Hydrochloride
10019-666BREVIBLOCesmolol hydrochloride
10019-668BREVIBLOCesmolol hydrochloride
10019-670BREVIBLOCesmolol hydrochloride
10019-672BREVIBLOCesmolol hydrochloride
52584-115BreviblocBrevibloc

Trademark Results [Brevibloc]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BREVIBLOC
BREVIBLOC
73433960 1287620 Live/Registered
American Hospital Supply Corporation
1983-07-08

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.